RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Resmed Stock

Resmed Net Income 2024

Resmed Net Income

1.02 B USD

Ticker

RMD

ISIN

US7611521078

WKN

895878

In 2024, Resmed's profit amounted to 1.02 B USD, a 13.75% increase from the 897.56 M USD profit recorded in the previous year.

The Resmed Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e1.7
2027e1.66
2026e1.53
2025e1.39
20241.02
20230.9
20220.78
20210.47
20200.62
20190.4
20180.32
20170.34
20160.35
20150.35
20140.35
20130.31
20120.25
20110.23
20100.19
20090.15
20080.11
20070.07
20060.09
20050.06

Resmed Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Resmed, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Resmed from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Resmed’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Resmed. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Resmed’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Resmed’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Resmed’s growth potential.

Resmed Revenue, EBIT and net profit per share

DateResmed RevenueResmed EBITResmed Net Income
2029e6.78 B undefined1.85 B undefined0 undefined
2028e6.34 B undefined2.14 B undefined1.7 B undefined
2027e5.92 B undefined1.96 B undefined1.66 B undefined
2026e5.53 B undefined1.82 B undefined1.53 B undefined
2025e5.16 B undefined1.67 B undefined1.39 B undefined
20244.69 B undefined1.38 B undefined1.02 B undefined
20234.22 B undefined1.15 B undefined897.56 M undefined
20223.58 B undefined1 B undefined779.44 M undefined
20213.2 B undefined917.58 M undefined474.51 M undefined
20202.96 B undefined809 M undefined621.7 M undefined
20192.61 B undefined636 M undefined404.6 M undefined
20182.34 B undefined560.2 M undefined315.6 M undefined
20172.07 B undefined456.7 M undefined342.3 M undefined
20161.84 B undefined435.9 M undefined352.4 M undefined
20151.68 B undefined409.2 M undefined352.9 M undefined
20141.56 B undefined411.4 M undefined345.3 M undefined
20131.51 B undefined379.5 M undefined307.1 M undefined
20121.37 B undefined294.4 M undefined254.9 M undefined
20111.24 B undefined269.2 M undefined227 M undefined
20101.09 B undefined240.4 M undefined190.1 M undefined
2009920.7 M undefined190.3 M undefined146.4 M undefined
2008835.4 M undefined145.3 M undefined110.3 M undefined
2007716.3 M undefined90.2 M undefined66.3 M undefined
2006607 M undefined132.4 M undefined88.2 M undefined
2005425.5 M undefined107.8 M undefined64.8 M undefined

Resmed stock margins

The Resmed margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Resmed. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Resmed.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Resmed's sales revenue. A higher gross margin percentage indicates that the Resmed retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Resmed's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Resmed's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Resmed's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Resmed. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Resmed's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Resmed Margin History

Resmed Gross marginResmed Profit marginResmed EBIT marginResmed Profit margin
2029e56.67 %27.37 %0 %
2028e56.67 %33.71 %26.82 %
2027e56.67 %33.05 %28.01 %
2026e56.67 %32.93 %27.6 %
2025e56.67 %32.45 %26.92 %
202456.67 %29.54 %21.79 %
202355.78 %27.28 %21.25 %
202256.57 %27.96 %21.78 %
202157.69 %28.7 %14.84 %
202058.09 %27.36 %21.02 %
201957.32 %24.4 %15.52 %
201857.04 %23.94 %13.49 %
201758.15 %22.1 %16.56 %
201658 %23.71 %19.17 %
201560.24 %24.37 %21.02 %
201463.65 %26.46 %22.21 %
201362.11 %25.06 %20.28 %
201259.97 %21.51 %18.63 %
201159.82 %21.66 %18.26 %
201060.01 %22.01 %17.4 %
200960.15 %20.67 %15.9 %
200859.11 %17.39 %13.2 %
200753.68 %12.59 %9.26 %
200662.09 %21.81 %14.53 %
200564.61 %25.33 %15.23 %

Resmed Aktienanalyse

What does Resmed do?

ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Resmed's Profit Margins

The profit margins of Resmed represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Resmed's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Resmed's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Resmed's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Resmed’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Resmed stock

How much profit has Resmed made this year?

Resmed has made 1.02 B USD this year.

How has the profit developed compared to last year?

The profit has increased by 13.75% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Resmed publish its earnings?

Resmed publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Resmed?

The profits of Resmed are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Resmed?

You can learn more about the earnings of Resmed by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Resmed pay?

Over the past 12 months, Resmed paid a dividend of 2.02 USD . This corresponds to a dividend yield of about 0.83 %. For the coming 12 months, Resmed is expected to pay a dividend of 2.31 USD.

What is the dividend yield of Resmed?

The current dividend yield of Resmed is 0.83 %.

When does Resmed pay dividends?

Resmed pays a quarterly dividend. This is distributed in the months of March, June, September, December.

How secure is the dividend of Resmed?

Resmed paid dividends every year for the past 0 years.

What is the dividend of Resmed?

For the upcoming 12 months, dividends amounting to 2.31 USD are expected. This corresponds to a dividend yield of 0.95 %.

In which sector is Resmed located?

Resmed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Resmed from 12/12/2024 amounting to 0.53 USD, you needed to have the stock in your portfolio before the ex-date on 11/7/2024.

When did Resmed pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Resmed in the year 2023?

In the year 2023, Resmed distributed 1.84 USD as dividends.

In which currency does Resmed pay out the dividend?

The dividends of Resmed are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Resmed stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Resmed

Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.